Wound News and Research

RSS

PharmaVentures announces global expansion of PharmaDeals Agreements

PharmaVentures, the company behind the PharmaDeals(R) range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.

19 Aug 2010

Emunamedica licenses technology for near-infrared wound monitor from Drexel University

Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.

19 Aug 2010

Scientists study yeast to understand human pathologies affecting male fertility

Men and yeast have something in common: they use the same molecular process to ensure the integrity of their gene pool during reproduction. This is a recent finding by researchers from CNRS, Inserm and the Université Joseph Fourier in Grenoble. The scientists are therefore set on studying yeast in order to shed light on the numerous cases of male infertility related to the malfunction of this process during spermatogenesis.

19 Aug 2010

Wound Management Technologies' CellerateRX introduced at DFWG congress in South Africa

Wound Management Technologies, Inc. announced today that its new international distributor, Spiramed (Pty) Ltd, exhibited its advanced wound care collagen product, CellerateRX® last weekend at the DFWG (Diabetic Foot Working Group) congress in Cape Town and has already planned exhibitions at two additional upcoming conferences. This second meeting of the DFWG congress was attended by over 120 diabetic foot specialists.

18 Aug 2010

SAGE to launch European Edition of 'Foot & Ankle Specialist'

SAGE is to launch Foot & Ankle Specialist - European Edition from February 2011. The journal will be an international edition of Foot & Ankle Specialist (FAS), a bimonthly controlled circulation journal launched in 2008 publishing peer-reviewed clinical information for foot and ankle caregivers.

18 Aug 2010

Study deems gentamicin-collagen sponge ineffective in reducing sternal wound infections

Contradicting previous study results, insertion of a sponge that contains the antibiotic gentamicin at the time of surgical closure following cardiac surgery did not reduce the rate of sternal wound infections after 3 months, compared to patients who did not receive the intervention, according to a study in the August 18 issue of JAMA.

18 Aug 2010

Equinox Surgical Solutions introduces SutureAssist device for streamlining suture management procedures

Equinox Surgical Solutions LLC today announced the launch of their new product, SutureAssist®, designed and developed by a minimally invasive, Board Certified, OB/GYN surgeon Dr. Warren Volker M.D., Ph.D. and his team to improve patient and surgical team safety. This proprietary device lets surgeons and scrub techs acquire, hand-off, dispose of and reload sutures with an efficient, one-handed motion resulting in significantly quicker wound closure and mitigation of both needle-stick risk to the surgical team and post-op needle management liability exposure.

18 Aug 2010

Smith & Nephew's Renasys EZ system infringes KCI's European patent

Kinetic Concepts, Inc. today announced that the German District Court in Mannheim has found that Renasys canisters and foam dressings used with Smith & Nephew plc's Renasys EZ system infringe KCI's German counterpart of European patent EP 0 853 950 patent relating to negative pressure wound therapy.

17 Aug 2010

Cytomedix second quarter 2010 revenue increases 102% to $1.15 million

Cytomedix, Inc. (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced financial results for the three and six months ended June 30, 2010.

17 Aug 2010

Study reveals how galectin-3 carbohydrate-binding protein promotes angiogenesis

A new study describes how a carbohydrate-binding protein, galectin-3, promotes angiogenesis, the growth of new blood vessels. Targeting the protein, scientists identified two approaches that significantly reduced angiogenesis in mice. These discoveries, published online August 16 in The Journal of Experimental Medicine, may lead to novel treatments for diseases caused by excessive angiogenesis, including age-related macular degeneration, cancer, and diabetes.

16 Aug 2010

NeoStem second-quarter revenues increase 26% to $19.4 million

NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.

16 Aug 2010

Interventional Spine completes another successful surgery with PERPOS Percutaneous Cervical System

Interventional Spine, Inc. today announced the completion of another successful surgery with the unique PERPOS Percutaneous Cervical System for the treatment of neck pain.

16 Aug 2010

Bicycle helmet laws need review: Health expert

Australia became the first country to make riding without a bicycle helmet illegal in 1991. Now health experts however have called for a change in existing helmet laws to encourage more people to ride bikes.

16 Aug 2010

Quick-Med Technologies, Biosara sign development agreement

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has signed a development agreement with Biosara Corporation, a medical device company targeting wound dressings for major medical and healthcare providers, along with the multi-billion dollar organized sports athlete markets.

13 Aug 2010

PROFIT magazine ranks Prollenium as one of Canada's Fastest Growing Companies

Ario Khoshbin, President of Prollenium Medical Technologies Inc., a privately held specialty medical device company, reported today that his firm will continue to record strong year on year gains in revenues and profitability for its 2010 Fiscal Year ending June 30th. Over the past five years, Prollenium has recorded aggregate revenue growth of more than 524% ranking it amongst Canada's fastest growing firms.

13 Aug 2010

SANUWAVE second-quarter revenues decrease to $117,000

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, today reported financial results for the three and six months ended June 30, 2010 and provided a business update.

13 Aug 2010

Derma Sciences second-quarter net sales increase 14% to $13.2 million

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2010.

13 Aug 2010

Wound Management Technologies introduces CellerateRX wound care collagen product in South Africa

Wound Management Technologies, Inc. is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement.

12 Aug 2010

Universal Hospital Services second-quarter total revenues increase 5.3% to $76.7 million

Universal Hospital Services, Inc., a leading provider of medical equipment management and service solutions, today announced financial results for the quarter and six months ended June 30, 2010.

12 Aug 2010

ITI signs NPWT contract with MAGNET

Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.

11 Aug 2010